Материалов:
1 081 645

Репозиториев:
30

Авторов:
761 409

По вашему запросу найдено документов: 1081645

Страница 1 из 108165

Potential uses of upadacitinib in rheumatoid arthritis and other inflammatory rheumatic diseases [ПЕРСПЕКТИВЫ ПРИМЕНЕНИЯ УПАДАЦИТИНИБА ПРИ РЕВМАТОИДНОМ АРТРИТЕ И ДРУГИХ ИММУНОВОСПАЛИТЕЛЬНЫХ РЕВМАТИЧЕСКИХ ЗАБОЛЕВАНИЯХ]
Nasonov E.L.
is upadacitinib (UPA), which has been registered for the treatment of RA and is undergoing clinical studies
Preclinical and clinical evidence of safety of antiviral drug with immunomodulatory activity [Pretklinički i klinički dokazi o bezbednosti antivirusnog leka sa imunomodulatornom aktivnošću]
Borovskaya T.G.
clinical trials, including those involving children aged 2 years and older. This confirms the safety
Cardiology news 2009: Arterial hypertension, primary and secondary prevention of atherosclerosis, antithrombotic therapy
Kobalava Zh.D., Kotovskaya Yu.V., Villevalde S.V., Averkov O.V.
clinical trial (topic)
Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply
Logunov D.Y.
phase 1 clinical trial (topic)
MiRNA regulated therapeutic potential of the stromal vascular fraction: Current clinical applications - A systematic review: SVF and miRNAs
Agaverdiev, Murad, Shamsov, Bedil, Mirzoev, Sorbon, Vardikyan, Andranik, Encarnacion, Manuel Ramirez, Nurmukhametov, Renat, Beilerli, Aferin, Zhang, Bohan, Gareev, Ilgiz, Pavlov, Valentin
into two stages. Results: By August 2022, there were 149 registered clinical trials. Most studies belong
Live attenuated reassortant vaccines based on A/Leningrad/134/17/57 master donor virus against H5 avian influenza
Kiseleva I.
Background: The H5N1 avian influenza was first recognized in humans in Hong Kong 20 years ago
Therapeutic drug monitoring (TDM) as intervention: A cross-sectional analysis of characteristics of 173 registered clinical trials
Zhao, Shanshan, Zaytseva, Olga, Zaytseva, Olga, Zhang, Boquan
Background: To examine fundamental characteristics of clinical trials with therapeutic drug
Angiotensin-receptor neprilysin inhibitor LCZ696; A novel therapy for heart failure
Mohammad B.I., Hadi N.R., Singh R.B., Shastun S., Sharmanov T., Tazhibayev S., Gumarova L.
phase 2 clinical trial (topic)
Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic
Bikson M.
regulatory restrictions may not have allowed for systematic planning of how clinical and research work may
Radiofrequency sympathetic renal denervation: A new version of the old method of treatment resistant hypertension
Shavarov A.A., Mayskov V.V., Kobalava Zh.D.
clinical trial (topic)

Страница 1 из 108165

Фасеты

Партнеры

КФУ
ТГУ
Elpub
СФУ
Webpublishers

Индексация

BASE
WorldCat
OpenAIRE
EDS
core